Perspective: The right trials

Patricia S. Steeg ()
Additional contact information
Patricia S. Steeg: Patricia S. Steeg is chief of the Women's Cancers Section, Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.

Nature, 2012, vol. 485, issue 7400, S58-S59

Abstract: The system for clinical trials must be redesigned if there is to be a decline in breast cancer metastasis, argues Patricia S. Steeg.

Date: 2012
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/485S58a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:485:y:2012:i:7400:d:10.1038_485s58a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/485S58a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().